Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 +0.00 (+0.49%)
As of: Oct 2, 2026 · 11:39 AM EDT

Abvc Biopharma (ABVC) Long-Term Investments (2018 - 2026)

Updated

Abvc Biopharma (ABVC) reported Long-Term Investments of $2.49 million for Q2 2026, down 12.3% from $2.84 million a year earlier but up 34.9% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Long-Term Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Abvc Biopharma posted Long-Term Investments of $1.88 million, down 16.8% from FY2024.

  • Long-Term Investments has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
  • By year, Long-Term Investments came in at $2.26 million in FY2024 (-10.6%), $2.53 million in FY2023 (+200.2%), $842,070 in FY2022 (-9.7%) and $932,755 in FY2021 (-21.7%).
  • Five-year quarterly Long-Term Investments spans a low of $816,160 in Q3 2022 and a high of $2.84 million in Q2 2025.
  • Year over year, Long-Term Investments has now declined in each of the last three quarters, with an average decline of 4.6% over the last eight quarters.
  • The high point for year-over-year Long-Term Investments in five years was Q3 2023 (growth of 228.0%); the low point was Q1 2026 (a decline of 33.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.85 million (Q1 2026), $1.88 million (Q4 2025) and $2.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Abvc Biopharma 27.31 Mn 29.30 Mn - 2.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.49 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.88 Mn
Sep 30, 2025 2.75 Mn
Jun 30, 2025 2.84 Mn
Mar 31, 2025 2.76 Mn
Dec 31, 2024 2.26 Mn
Sep 30, 2024 2.33 Mn
Jun 30, 2024 2.38 Mn
Mar 31, 2024 2.47 Mn
Dec 31, 2023 2.53 Mn
Sep 30, 2023 2.68 Mn
Jun 30, 2023 831,706.00
Mar 31, 2023 849,843.00
Dec 31, 2022 842,070.00
Sep 30, 2022 816,160.00
Jun 30, 2022 870,571.00
Mar 31, 2022 904,254.00
Dec 31, 2021 932,755.00
Sep 30, 2021 1.01 Mn
API Access

Abvc Biopharma Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY